Axxam Advances its High-Throughput Screening with Genedata Screener

Axxam, a leading contract research and discovery company focused on collaborative research programs for the life science industry, announced today that it is advancing its high-throughput screening services with Genedata Screener. Axxam tailors its high-throughput screening to specific discovery processes and effectively address challenging targets and multi-client/project research on a single platform. Axxam analyzes data produced by screening cellular or biochemical assays, based on fluorescence or luminescence readouts, The system’s high-performance data analysis across the entire screening cascade, support Axxam early-stage therapeutic discoveries in different therapeutics areas. Genedata Screener functionality accelerates the hit-to-lead process, optimizing researchers’ time and Axxam resources.

Open PDF document